title: Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms.
abstract: OBJECTIVE
  To investigate the risk factors for infection of the diabetic foot with multidrug resistant microorganisms.
  
  
  METHODS
  Amongst 102 diabetic patients with evidence of soft tissue infection of the foot who presented to our health center over a three year period, we investigated risk factors that might be predictive of multi-antibiotic resistance of the infecting organism.
  
  
  RESULTS
  Of 102 patients with a diabetic foot wound, bacteria were cultured from 73, yielding a total of 104 isolates. The number of multidrug resistant isolates was 42 from 36 cases and the number of isolates other than multidrug resistant ones was 62 from 37 cases. Previous antibiotic therapy (p=0.002) and its duration (p=0.0001), frequency of hospitalization for the same wound (p=0.000), duration of hospital stay (p=0.000) and osteomyelitis (p=0.001) were significant risk factors for infections with multidrug resistant microorganisms.
  
  
  CONCLUSIONS
  In conclusion, an appropriate antibiotic should be initiated promptly, wound perfusion should be effective, duration of hospital stay should be as short as possible and optimum hygiene should be provided during wound care to prevent infections of diabetic foot wound with multidrug resistant microorganisms.
authors.affiliation: Department of Clinical Microbiology and Infectious Diseases, Mersin University, Faculty of Medicine, Zeytinli Bahçe caddesi, 33079 Mersin, Turkey. kandemirege@hotmail.com
authors.forename: Ozlem
authors.initials: O
authors.lastname: Kandemir
authors.forename: Esen
authors.initials: E
authors.lastname: Akbay
authors.forename: Elif
authors.initials: E
authors.lastname: Sahin
authors.forename: Abtullah
authors.initials: A
authors.lastname: Milcan
authors.forename: Ramazan
authors.initials: R
authors.lastname: Gen
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D017719:Diabetic Foot / Q000150:complications* / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006090:Gram-Negative Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006094:Gram-Positive Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy / Q000382:microbiology; D012307:Risk Factors; D014946:Wound Infection / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents